Medgel Private Limited - Due diligence report

A 360° intelligence report on Medgel Private Limited: trust score, financial health, credit view, compliance, directors, growth and distress…

2007-01-10 Indore, Madhya Pradesh Active Unlisted Active Compliant
Share
Connect MCP
MP Medgel Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Medgel Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
86/100
Trust Score
Low Risk

Medgel Private Limited is assessed as Low Risk with a Trust Score of 86/100. Medgel Private Limited is an active private limited indian non-government company incorporated in 2007, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 04 Aug 2026 from the latest processed filings. Medgel Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
86/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
85/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 85/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 2 open (8.30 cr) · 4 satisfied (24.32 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others3 48.0 cr
Idbi Bank Limited2 48.0 cr
Hdfc Bank Limited1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ASHOK AGRAWAL OMPRAKASH 01234567 Director 01/04/2018 6 yrs Approved
AKSHIT GARG 01234567 Director 01/04/2018 6 yrs Approved
MANISHA GARG 01234567 Director 01/04/2018 6 yrs Approved
PRAVEEN NALWAYA 01234567 Director 01/04/2018 6 yrs Approved
LOKESH PARMAR 01234567 Director 01/04/2018 6 yrs Approved
VAIBHAV SINGHAI 01234567 Director 01/04/2018 6 yrs Approved
RAMESH CHANDRA MITTAL 01234567 Director 01/04/2018 6 yrs Approved
ALOK K GARG 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Medicaps Limited
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Medicaps Limited Holding Company 74.00%

Key managerial personnel: MANISHA GARG (Whole-time director) · PRAVEEN NALWAYA (Whole-time director) · LOKESH PARMAR (CFO) · ALOK K GARG (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 65
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Operating for 19+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Profit declined two years in a row.
2 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence85/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment84/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 8.30 cr already registered.
  • Compliance record supports lending.
Investor view74/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
17 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
11 Jul 2024
Charge created
Others - 80.00 Lakh
14 Dec 2023
Director appointed
VAIBHAV SINGHAI (Company Secretary)
12 Oct 2023
Charge satisfied
Others
02 Aug 2023
Charge satisfied
Hdfc Bank Limited
03 Jul 2023
Charge satisfied
Others
20 Mar 2023
Charge created
Others - 20.00 cr
01 Jul 2022
Charge satisfied
Idbi Bank Limited
05 May 2022
Charge created
Hdfc Bank Limited - 2.00 cr
09 Feb 2022
Charge created
Others - 31.50 Lakh
30 Dec 2020
Director ceased
ASHOK AGRAWAL OMPRAKASH
03 Feb 2020
Director appointed
ASHOK AGRAWAL OMPRAKASH (Director)
20 Nov 2019
Director appointed
AKSHIT GARG (Director)
01 Oct 2019
Director ceased
MANISHA GARG
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
8 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Vinyl Chemicals Private Limited U24110TG1985PTC005825 Hyderabad, Telangana, India
Satramdas Gases Private Limited U15132MH1992PTC065376 Thane, Maharashtra, India
Lantech Pharmaceuticals U24232TG2008PLC058745 Hyderabad, Telangana, India
Jainson Organics Pvt Ltd U24241MP1987PTC004213 Indore, Madhya Pradesh, India
Jc Biotech U65993TG1991PTC013624 Hyderabad, Telangana, India
Asha Dyestuff Industries Private Limited U24114MH1990PTC058224 Mumbai, Maharashtra, India
Alpha Chemicals Private Limited U24110MH1997PTC109306 Panvel, Maharashtra, India
Dhara Lifescience Private Limited U24232GJ2007PTC050530 Ahmedabad, Gujarat, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Medgel Private Limited before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Medgel Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 85/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Medgel Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 86/100, distress signals and MSME payment-delay disclosures - know whether Medgel Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Medgel Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Medgel Private Limited an active company?

Medgel Private Limited has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Medgel Private Limited financially healthy?

Medgel Private Limited has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.

Should I do business with Medgel Private Limited?

Its overall Trust Score is 86/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Medgel Private Limited?

The ultimate holding entity is Medicaps Limited. 8 active director(s) are on record.

Does Medgel Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets, and 4 earlier charge(s) stand satisfied.

Is Medgel Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Medgel Private Limited?

Its Credit Risk Score is 85/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.